According to Quest Diagnostics 's latest financial reports the company's total liabilities are $7.60 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | $7.60 B | 11.33% |
2022-12-31 | $6.83 B | -3.11% |
2021-12-31 | $7.04 B | -1.21% |
2020-12-31 | $7.13 B | 0.78% |
2019-12-31 | $7.08 B | 25.11% |
2018-12-31 | $5.65 B | 3.49% |
2017-12-31 | $5.46 B | 1.96% |
2016-12-31 | $5.36 B | 3.55% |
2015-12-31 | $5.17 B | -6.3% |
2014-12-31 | $5.52 B | 11.1% |
2013-12-31 | $4.97 B | -2.41% |
2012-12-31 | $5.09 B | -8.94% |
2011-12-31 | $5.59 B | 25.15% |
2010-12-31 | $4.47 B | -1.73% |
2009-12-31 | $4.55 B | -5.14% |
2008-12-31 | $4.79 B | -8.44% |
2007-12-31 | $5.24 B | 98.37% |
2006-12-31 | $2.64 B | 3.9% |
2005-12-31 | $2.54 B | 32.79% |
2004-12-31 | $1.91 B | 0.44% |
2003-12-31 | $1.90 B | 22.59% |
2002-12-31 | $1.55 B | -2.46% |
2001-12-31 | $1.59 B |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
LabCorp LH | $8.83 B | 16.18% | ๐บ๐ธ USA |
Psychemedics PMD | $6.67 M | -99.91% | ๐บ๐ธ USA |
NeoGenomics
NEO | $0.73 B | -90.27% | ๐บ๐ธ USA |
Qiagen QGEN | $2.30 B | -69.66% | ๐ณ๐ฑ Netherlands |
Enzo Biochem ENZ | $28.3 M | -99.63% | ๐บ๐ธ USA |